Zydus launches affordable biosimilar 'Zyrifa' for cancer-related bone complications
Zyrifa is indicated for patients with bone metastases stemming from a wide range of solid tumors
Zyrifa is indicated for patients with bone metastases stemming from a wide range of solid tumors
The patented product, developed by Venus Medicine Research Centre (VMRC) for the treatment of multidrug-resistant (MDR) infections, was sold to Cipla in 2019
This campaign is to raise awareness about the crucial role helmet usage plays in saving lives
Renalyx will continue operating as an independent unit within the group
Venus Remedies now has 29 active product approvals in Vietnam alone
The upcoming state-of-the art 400+ bed facility is set to come up at an approximate cost of Rs 500 crore
Glenmark’s Ropivacaine Hydrochloride Injection USP is bioequivalent and therapeutically equivalent to the reference listed drug Naropin Injection of Fresenius Kabi USA
The Hub & Spoke model is designed to extend advanced medical care to a wider community
Terufusion Advanced Infusion Systems combine a smart syringe pump, smart infusion pump, and pump monitoring system software for precise and efficient drug administration
Subscribe To Our Newsletter & Stay Updated